These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 467382)

  • 41. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD; Lantigua R; Lee LA
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thyroid hormones and catecholamines in the regulation of pituitary secretion of the somatotrophic hormone].
    Peracchi M; Cavagnini F
    Folia Endocrinol; 1971; 24(3):211-6. PubMed ID: 5171721
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA].
    Carducci Artenisio A; Ragonese F; Alibrando A; Forte F; Mancuso T; Consolo F
    Minerva Med; 1979 May; 70(23):1681-6. PubMed ID: 109792
    [No Abstract]   [Full Text] [Related]  

  • 44. [GH secretion after L-dopa administration in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Fedeli G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Oct; 67(47):3027-32. PubMed ID: 967366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evoked hypercalcemia test and the pentagastrin test in assessing the functional state of the parafollicular apparatus of the thyroid in hyper- and hypothyroidism].
    Pavlova L
    Vutr Boles; 1977; 16(4):34-9. PubMed ID: 919510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F; Villanueva L; Peñalva A; Rodríguez R; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):217-20. PubMed ID: 482694
    [No Abstract]   [Full Text] [Related]  

  • 48. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F; Villanueva L; Peñalva A; Barrionuevo JA; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):221-4. PubMed ID: 482695
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of domperidone on serum TSH and growth hormone in thyroid patients.
    Földes J; Bános C; Lakatos P; Takó J
    Acta Med Hung; 1985; 42(3-4):133-43. PubMed ID: 4094840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Usefulness of the ETR test in the assessment of thyroid function in children].
    Prochorow M; Wlodarz A; Tustanowski S
    Pediatr Pol; 1975 Sep; 50(9):1131-6. PubMed ID: 1165943
    [No Abstract]   [Full Text] [Related]  

  • 52. [Development of a simple oral short test with the TSH releasing hormone (TRH) and its use in thyroid diagnosis].
    Staub JJ; Girard J; Gemsenjäger E
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1839-42. PubMed ID: 827812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of hypothyroidism duration on developmental changes in the hypothalamic factors implicated in growth hormone secretion in the male rat.
    Varela C; Cacicedo L; Fernández G; de los Frailes T; Sánchez Franco F
    Neuroendocrinology; 1991 Oct; 54(4):340-5. PubMed ID: 1684642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C; Höffken B; Morgner KD
    Verh Dtsch Ges Inn Med; 1974; 80():1328-30. PubMed ID: 4454413
    [No Abstract]   [Full Text] [Related]  

  • 55. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
    Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
    Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
    [No Abstract]   [Full Text] [Related]  

  • 56. [A thyroid function test--the determination of Achilles tendon reflex time (author's transl)].
    Zhang HF
    Zhonghua Nei Ke Za Zhi; 1980 Nov; 19(6):458-60. PubMed ID: 7297267
    [No Abstract]   [Full Text] [Related]  

  • 57. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T; Tiyapan A; Rajatanavin R; Pitchayayothin N
    J Med Assoc Thai; 1981 Jan; 64(1):19-25. PubMed ID: 7217816
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
    Shi YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):168-72. PubMed ID: 2150352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism].
    Gembicki M; Sobieszczyk S; Kosowicz J
    Endokrynol Pol; 1979; 30(2):155-61. PubMed ID: 467382
    [No Abstract]   [Full Text] [Related]  

  • 60. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C; Pumarino H; Michelsen H; Piraino P; Generini G; Bruggendieck B
    Rev Med Chil; 1985 Apr; 113(4):296-300. PubMed ID: 3915142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.